tiprankstipranks
HTG Molecular Diagnostics (HTGMQ)
OTHER OTC:HTGMQ
US Market

HTG Molecular Diagnostics (HTGMQ) Financial Statements

458 Followers

HTG Molecular Diagnostics Financial Overview

HTG Molecular Diagnostics's market cap is currently $2.00. The company's EPS TTM is $; its P/E ratio is ―; HTG Molecular Diagnostics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue$ 6.37M$ 8.91M$ 8.55M$ 19.20M$ 21.50M
Gross Profit$ 1.79M$ 4.81M$ 4.56M$ 10.29M$ 16.41M
Operating Income$ -20.83M$ -17.82M$ -19.59M$ -18.96M$ -16.16M
EBITDA$ -20.14M$ -15.36M$ -18.48M$ -17.08M$ -14.08M
Net Income$ -21.59M$ -17.15M$ -20.87M$ -19.30M$ -16.45M
Balance Sheet
Cash & Short-Term Investments$ 12.21M$ 21.94M$ 28.70M$ 33.03M$ 31.11M
Total Assets$ 17.78M$ 30.46M$ 35.20M$ 45.12M$ 43.77M
Total Debt$ 8.35M$ 11.71M$ 12.64M$ 11.25M$ 9.68M
Net Debt$ -3.86M$ 2.11M$ -9.75M$ 3.63M$ 1.25M
Total Liabilities$ 12.39M$ 20.06M$ 20.71M$ 21.15M$ 22.68M
Stockholders' Equity$ 5.39M$ 10.40M$ 14.48M$ 23.97M$ 21.09M
Cash Flow
Free Cash Flow$ -18.43M$ -17.15M$ -16.75M$ -17.80M$ -14.12M
Operating Cash Flow$ -18.41M$ -16.51M$ -16.29M$ -16.70M$ -13.17M
Investing Cash Flow$ 12.42M$ -6.66M$ 18.73M$ -3.50M$ -23.22M
Financing Cash Flow$ 8.60M$ 10.39M$ 9.05M$ 19.39M$ 38.13M
Currency in USD

HTG Molecular Diagnostics Earnings and Revenue History

HTG Molecular Diagnostics Debt to Assets

HTG Molecular Diagnostics Cash Flow

HTG Molecular Diagnostics Forecast EPS vs Actual EPS